Doç. Dr. Deniz Işık

Doctor and researcher Emsey Hospital İstanbul
Breast NeoplasmsLung NeoplasmsCarcinoma, Non-Small-Cell Lung
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Breast Neoplasms 15 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Lung Neoplasms 7 publications
  • Carcinoma, Non-Small-Cell Lung 5 publications

Person ↔ Disease

Which topics does this doctor work on?

From source

Medical areas of interest stated by the doctor on the institution profile. Source: emseyhospital.com.tr.

  • Kişiye Özel Akıllı İlaç Tedavisi
  • İmmünoterapiler
  • Akciğer Kanseri
  • Meme Kanseri
  • Bağırsak Kanseri ( Kolorektol kanserler)
  • Prostat Kanseri
  • Mide ve Yemek Borusu Kanseri
  • Böbrek ve İdrar Kesesi Kanseri
  • Kadın Doğum Kanserleri
  • Beyin, Baş ve Boyun Kanserleri
  • Kanserde Beslenme ve Destek Tedavileri

CV

Education and experience

From source

Experience

  • Experience2023 - 2026 KARTAL DR. LÜTFİ KIRDAR ŞEHİR HASTANESİemseyhospital.com.tr
  • Experience2019 - 2023 VM MEDICAL PARK KOCAELİ HASTANESİemseyhospital.com.tr
  • Experience2017 - 2019 GAZİANTEP DR. ERSİN ARSLAN EĞİTİM ARAŞTIRMA HASTANESİemseyhospital.com.tr
  • Experience2013 - 2014 BATMAN BÖLGE DEVLET HASTANESİemseyhospital.com.tr
  • Experience2008 - 2009 DİYARBAKIR 5 NOLU 112 SAĞLIK HİZMETLERİ İSTASYONUemseyhospital.com.tr

Education

  • 2014-2017İstanbul Kartal Lütfi Kırdar Eğitim ve Araştırma Hastanesi Yandal Uzmanlıkemseyhospital.com.tr
  • 2009-2013İzmir Atatürk Eğitim ve Araştırma Hastanesi Uzmanlık Eğitimiemseyhospital.com.tr
  • 2002-2008Dicle Üniversitesi Tıp Fakültesiemseyhospital.com.tr

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • Department name at the sourceOnkolojiemseyhospital.com.trFrom source
  • InstitutionEmsey Hospitalemseyhospital.com.trFrom source
  • Area of workBreast NeoplasmsExtracted from 15 publications · Model version —From source
  • Publications94 publicationsOpenAlexFrom source
  • Last synchronised4 November 2026 20:51https://www.emseyhospital.com.tr/hekimlerimiz/deniz-isikemseyhospital.com.tr

Scientific work

Publications on Breast Neoplasms

94 publications

  1. Prognostic Impact and Clinicopathological Correlates of HER2 Status in Gastric Cancer: A Multicenter Retrospective Turkish Oncology Group Study

    Clinical Medicine Insights Oncology, 2026

    DOI 10.1177/11795549261445290 PMID 42131419 Open-access full textSource: OpenAlex

  2. Association Between Time to PSA Nadir, Radiologic Progression, and PSA Progression in mHSPC Patients Treated with Abiraterone or Enzalutamide

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15010386 PMID 41517635 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  3. Impact of Peri-Immunotherapy Antibiotic Exposure on Survival Outcomes in Metastatic Renal Cell Carcinoma: A Real-World IMDC Risk–Stratified Analysis

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15051853 PMID 41827267 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  4. Nutritional Indexes and Their Variations as Predictors of Atezolizumab Plus Chemotherapy Efficacy in Extensive-Stage Small Cell Lung Cancer: A Turkish Oncology Group Study

    Journal of Immunotherapy, 2026

    DOI 10.1097/cji.0000000000000610 PMID 42267536 Source: OpenAlex

  5. Prognostic value of PSA Kinetic Ratio in high-volume mCSPC patients treated with abiraterone or enzalutamide: a single-center retrospective study

    BMC Cancer, 2026

    DOI 10.1186/s12885-026-16037-8 PMID 41987096 Open-access full textSource: OpenAlex

  6. Association between GRIm score and response to nivolumab monotherapy in patients with advanced malignant melanoma

    Journal of Cancer Research and Clinical Oncology, 2026

    DOI 10.1007/s00432-025-06411-7 PMID 41504775 3 citations (Europe PMC) Open-access full textSource: OpenAlex

  7. Adjuvant Chemotherapy and Chemoradiotherapy in Gastric Cancer: Prognostic Determinants and Real-World Survival Outcomes

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15020553 PMID 41598493 Open-access full textSource: OpenAlex

  8. Clinical Outcomes of Stage IS Non-seminomatous Germ Cell Testicular Tumors: Single-Center Experience

    Istanbul Medical Journal, 2026

    DOI 10.4274/imj.galenos.2026.62829 Open-access full textSource: OpenAlex

  9. Association Between Body Mass Index and Clinical Outcomes of CDK4/6 Inhibitors in HR+/HER2− Metastatic Breast Cancer: A Real-World Cohort Study

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15041671 PMID 41753358 Open-access full textSource: OpenAlex

  10. 657eP Time toxicity of CDK4/6 inhibitors in HR+/HER2- metastatic breast cancer: A real-world comparative study of palbociclib and ribociclib

    ESMO Open, 2026

    DOI 10.1016/j.esmoop.2026.107673 Source: OpenAlex

View all 94 publications